An Implicit Understanding of Research
Our approach is research led and we have a proven commitment to supporting medical progress through several research funds.
Our robust blend of technical, regulatory, scientific, clinical and commercial capabilities ensures a high likelihood of success in bringing new products to market.
A History of Success
We have an impressive track record in successfully commercialising medical innovations such as INOmax® for pulmonary hypertension in neonates.
A Remarkable Reach
We have a global presence with operations in 50 countries including the key growth centres of China and India.
We are present across healthcare, including hospital, critical care, intermediate therapy and home care.